Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (851-860 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|February 1, 1996
Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disordersL R Wiseman, D Faulds
Drugs|February 1, 1996
Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failureC J Dunn, A Markham
Drugs|February 1, 1996
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disordersC M Perry, R N Brogden
Drugs|January 1, 1996
Diagnosis of osteoarthritis. Guidelines and current pitfallsG Bálint, B Szebenyi
Drugs|January 1, 1996
Nonpharmacological approaches to pain in osteoarthritis. Available optionsS Perrot, C J Menkes
Drugs|January 1, 1996
Pharmacology and clinical experience with tramadol in osteoarthritisW A Katz
Drugs|January 1, 1996
How do calcium channel blockers prevent cardiovascular events. Are they all alike?M G Bogaert
Drugs|January 1, 1996
Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCAA Vahanian, B Lung
Drugs|August 1, 1996
The implications of noncompliance with antihypertensive medicationB Girvin, G D Johnston
Drugs|August 1, 1996
Recognition and treatment of unstable anginaC Brunelli, P Spallarossa, P Rossettin, et al.
Pageof 708

Showing results (851-860 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|February 1, 1996
Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disordersL R Wiseman, D Faulds
Drugs|February 1, 1996
Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failureC J Dunn, A Markham
Drugs|February 1, 1996
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disordersC M Perry, R N Brogden
Drugs|January 1, 1996
Diagnosis of osteoarthritis. Guidelines and current pitfallsG Bálint, B Szebenyi
Drugs|January 1, 1996
Nonpharmacological approaches to pain in osteoarthritis. Available optionsS Perrot, C J Menkes
Drugs|January 1, 1996
Pharmacology and clinical experience with tramadol in osteoarthritisW A Katz
Drugs|January 1, 1996
How do calcium channel blockers prevent cardiovascular events. Are they all alike?M G Bogaert
Drugs|January 1, 1996
Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCAA Vahanian, B Lung
Drugs|August 1, 1996
The implications of noncompliance with antihypertensive medicationB Girvin, G D Johnston
Drugs|August 1, 1996
Recognition and treatment of unstable anginaC Brunelli, P Spallarossa, P Rossettin, et al.
Pageof 708